HCV In At Risk Populations: Who Can be Treated and How? |
| |
Authors: | Anthony D Martinez Robert G Gish |
| |
Institution: | 1. Division of General Internal Medicine and Hepatology, University of California San Diego, 200 West Arbor Drive, San Diego, CA, 92103-8413, USA 2. Center for Hepatobiliary Disease and Abdominal Transplantation, University of California San Diego, 350 Dickinson St. Suite 342, San Diego, CA, 92103-8413, USA
|
| |
Abstract: | Hepatitis C virus (HCV), a major cause of chronic liver disease, affects an estimated 5 million people in the Unites States
1] and close to 170 million people worldwide. Certain subpopulations including injection drug users, prison inmates, the homeless,
ethnic minorities, American veterans, and HIV co-infected patients are considered high risk for viral acquisition and are
disproportionately affected by HCV. This review describes the prevalence of HCV in these at-risk populations including those
with cirrhosis, chronic kidney disease (CKD), solid organ transplantation and presents current treatment options. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|